Device Trial Radar · NCT00582946
Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding
Last checked: Nov 20, 2026Latest source record: Nov 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
May 2006
Primary completion
Dec 2009
Study completion Dec 2009
Sponsor
- Lead sponsor
- EarLens CorporationNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- First posted
- Dec 28, 2007
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Our goal is to design and build a new hearing aid system, which mitigates the most common complaints that hearing aid users have. These include hearing in multi-talker situations, poor sound quality, unwanted whistling resulting from feedback, and a dislike of the sound of their own voice. Current efforts, with limited success, use signal processing methods rather than restoring more closely the normal auditory function. We plan to achieve our goal by reducing to practice three key enabling concepts. The first is to replace the current acoustic transducer with a non-acoustic mechanical output transducer that directly actuates the tympanic membrane (TM). This transducer, called the EarLens, floats on the tympanic membrane in a manner similar to the way a contract lens floats on the eye. The second is to increase the output bandwidth of the hearing aid. The third key concept is to place a wide-bandwidth microphone in the ear canal to capture the pinna diffraction cues similarly to the way the normal ear functions. Our central hypothesis is that a hearing aid that delivers amplified wide-bandwidth mechanical stimuli, directionally dependent cues, in an open canal configuration will perform better than conventional hearing aids when there are competing talkers in the background. First phase includes verification the capability of the system to deliver sufficient maximum equivalent pressure output (MEPO) to treat the degree of hearing loss in the target fitting range.
Conditions
- Hearing Impairment
Interventions
Hearing AidDevice
Subjects were treated with a hearing aid which provided amplification intended to treat mild to moderate sensorineural hearing loss.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Effective Sound Pressure Level (MEPO)Time frame: 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ear Lens Corporation
Redwood City, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.